IGF2BP1 and nasopharyngeal carcinoma: Similarly, knockdown of lnc-HTOR or IGF2BP1 by CRISPR/Cas9 gene-editing methods mimicked the effects and abolished the requirement for Triptonide in nasopharyngeal carcinoma cells (Liu et al., 2016).